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Abstract
Background: Unilateral spatial neglect (USN) is characterized by the inability to report or respond to people or
objects that are presented in the spatial hemisphere that is contralateral to the lesioned hemisphere of the brain.
USN has been associated with poor functional outcomes and long stays in hospitals and rehabilitation centers.
Noninvasive brain stimulation, such as transcranial direct current stimulation (tDCS), has been used in people who
have been affected by USN after stroke. The effects of such treatment could provide new insights for health
professionals and policy-makers. The aim of this study will be to evaluate the effectiveness and safety of tDCS for
USN after stroke.
Methods: A prospective randomized controlled trial with two parallel groups will be conducted, which will
aim to recruit 60 patients with USN after ischemic or hemorrhagic stroke. Participants will be randomly placed
into the following four treatment groups: (1) anodal tDCS over the right parietal lobe (n = 15), (2) cathodal
tDCS over the left parietal lobe (n = 15), (3) a sham group of anodal tDCS over the right parietal lobe (n = 15),
and (4) a sham group of cathodal tDCS over the left parietal lobe (n = 15). Blinded assessors will conduct two baseline
assessments and one post-intervention assessment. The primary outcome measure will be the level of USN as assessed
by the conventional Behavioral Inattention Tasks and the Catherine Bergego Scale. Secondary measures will include
neurological capacity (based on the Scandinavian Stroke Scale), functional capacity (based on the Functional
Independence Measure and Modified Rankin Scale), autonomy (based on the Barthel Index), and quality of life (based
on the EuroQol-5D). Group allocation will be concealed, and all analyses will be based on an intention-to-treat principle.
Discussion: This study will explore the effects of more than 15 sessions of tDCS on the level of USN, functional capacity,
autonomy, and quality of life in patients with USN after stroke. This proposed study has the potential to identify a new,
evidence-based intervention that can enhance perception and independent living in patients with USN after stroke.
Trial registration: REBEC - RBR-78jvzx, registered on 13 March 2016.
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Background
Unilateral spatial neglect (USN) clinically manifests
when an individual does not respond to any tactile or
visual stimulus on one side of the body or hemispherical
space. Such unresponsiveness cannot be attributed to a
sensory deficit or a primary motor deficit. This condition
makes it difficult for a patient to report, respond to,
guide, or interpret any stimulus that is received from the
affected side [1–3]. Often a USN is associated with le-
sions in the right hemisphere of the brain, particularly in
the parietal lobe [4–7], or the right posterior parietal
lobe [8, 9]. USN is associated with a poor prognosis and
the need for long periods of hospitalization [10–14].
Currently, the procedures that are used to evaluate
USN are composed of tasks that use pen and paper to
distinguish cancellation targets or simultaneous touch
[15, 16]. Four tests have been proposed to assess USN,
namely, the Face-Hand Test (FHT), which is used to
promote simultaneous dual sensory stimulation in indi-
viduals [17–19]; the Line Cancellation Task [20, 21] or
Star Cancellation [22], both of which are used to grade
the severity of the USN based on the number of lines or
stars cancelled; and the Line Bisection Task [23, 24]
which is used to observe deviation from the midline of a
space. The cancellation and bisection tests are used con-
sistently in the clinic and exhibit high sensitivity and
specificity for detecting USN [25, 26]. In addition to
the cancellation and bisection tests, Azouvi et al.
(2003) developed a specific scale based on 10 activ-
ities of daily living that can be changed by USN. This
scale is typically used during the chronic period after
a stroke to measure the efficacy of the treatments for
symptom regression [27].
Since the early 1970s, various rehabilitation techniques
have been proposed to reduce the disability that is
caused by USN after stroke. Among them include
techniques for noninvasive neuromodulation through
brain stimulation, such as, transcranial magnetic stimu-
lation (rTMS) and transcranial direct current stimulation
(tDCS), which create low-intensity electrical currents
in the brain to change the excitability of cortical re-
gions [28, 29]. Recent studies suggest that noninvasive
brain stimulation techniques can aid in the rehabilita-
tion of patients with stroke to promote the recovery
of function [30–33].
tDCS reversibly polarizes regions of the brain via the
topical application of low-intensity direct currents to
change the potential and modulation of transneuronal
membrane excitability levels and firing rates [31, 34].
The tDCS-induced polarization effect in the brain varies
depending on electrode polarity, wherein the anodal
stimulation (positive electrode) increases cortical excit-
ability, while the cathodal stimulation (negative elec-
trode) decreases excitability [35]. Recent human studies
have shown that anodal polarization increases the excit-
ability of the motor, visual, and prefrontal cortices, with
an improved performance of motor skills [36], working
memory [37], and verbal fluency [38].
Few studies have been designed to evaluate the effect
of tDCS on the USN syndrome after stroke. A random-
ized controlled trial conducted by Ko et al. (2008) in 15
patients with USN after stroke observed improvements
in the performance of the Line Cancellation Task, Figure
and Shape Copying, and the Line Bisection Task after
anodal polarization using tDCS of the right posterior
parietal region [39]. Using tDCS in 10 patients with
USN after stroke, Sparing et al. (2009) observed that in-
hibitory cathodal stimulation applied to the uninjured
posterior parietal cortex, and excitatory anodal stimula-
tion of the lesioned posterior parietal cortex, reduced
the degree of USN [40].
In a clinical trial conducted in 10 patients with USN
after stroke in the chronic phase, Sunwoo et al. (2013)
evaluated the following three types of stimulation: (1)
simultaneous anodal stimulation to the right parietal
cortex and cathodal stimulation to the left parietal
cortex, (2) single-mode anodal stimulation to the right
parietal cortex, and (3) sham stimulation to control for
the placebo effect. The authors observed an improve-
ment in the performance of the Line Bisection Tasks for
the simultaneous and single-mode stimulation types.
Moreover, the effect for simultaneous stimulation was
greater than that compared to the other two stimulation
types [41]. A recent study evaluated the application of
tDCS in five sessions, each of 20 min, in five individuals
with USN in the chronic phase of stroke. Cathodal
stimulation was applied to the P3 region (left parietal
cortex) and anodal stimulation was applied to the P4
region (right parietal cortex) according to the inter-
national electroencephalogram system. The results were
not statistically significant and the degree of USN was
not reduced at the end of treatment. These results sug-
gest that randomized controlled trials should include the
highest possible number of patients [42].
USN after stroke can be caused by a hemispherical im-
balance of cerebral electrical activity with the injured
area showing no decrease in cortical excitability. Recent
studies suggest that spatial perception could be im-
proved by restoring the balance of hemispherical activity
through tDCS [40–43]. In addition, USN has been asso-
ciated with a worse functional outcome, a longer reten-
tion of patients in rehabilitation centers, a high risk of
falls, and the need for a wheelchair. Such outcomes de-
crease productivity and quality of life compared to other
patients without USN after stroke [13, 14, 43].
Several studies have reported that tDCS can improve
performance in tasks that assess spatial orientation after
USN such as Line Bisection and Line Cancellation Tasks.
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However, these studies do not report a complementary
reduction in long-term disability or an improvement
in patient quality of life. Because tDCS is a cost-
effective noninvasive procedure for brain stimulation
compared to, for example, magnetic stimulation, we
propose the present research to try to establish
whether it could in fact lead to the aforementioned
quality of life improvements.
Aims
The principal objective of this study in patients with
USN after stroke is to evaluate the efficacy and safety of
15 sessions of tDCS versus placebo in ameliorating USN.
We hypothesize that tDCS will induce changes in the
neuronal activity of the posterior parietal lobe that will
reduce USN presentation in patients after stroke.
In addition, we will assess the effects of tDCS on the
capacity of function, level of paralysis, and quality of life.
Methods
Design
This single-center, randomized, placebo-controlled,
double-blind, parallel-group study of 60 patients with
USN will be conducted in accordance with the Con-
solidated Standards of Reporting Trials (CONSORT)
2010 flow diagram [44] (Figs. 1 and 2).
Sample size
We estimate a minimum sample size per group of 15
assuming: simple random sampling; type I and II error
probabilities equal 0.05 and 0.20, respectively; the ab-
sence of confounders; normal distribution for the out-
come “percentage of deviation” with a mean baseline
equal to a 15 % reduction in the outcome after tDCS;
an estimated reduction of between 8 and 3 % for the
sham group; and a variation coefficient of 20 %.
Fig. 1 Study flow diagram for anodal transcranial direct current stimulation (tDCS) stimulation
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Location and setting
All assessments will be conducted at the Botucatu
Medical School within the Department of Neurology
and Center of Rehabilitation, Botucatu, Brazil.
Participants
Inclusion criteria
Individuals of 18–85 years of age and of either sex, with
USN after stroke diagnosis within 15 weeks of the start
of stroke symptoms, will be included in this study. The
patients will be recruited in the stroke unit by Botucatu
Medical School, and will include patients with right-
hand ischemic or hemorrhagic stroke in the right
parietal lobe confirmed using computed tomography
(CT) or magnetic resonance imaging (MRI). USN will be
objectively diagnosed by conventional Behavior Inatten-
tion Tasks (BIT-C) with a cutoff of >129.
Exclusion criteria
Excluded individuals will include any patients with
metal-in-cranium injuries near the electrode placement
area, a cardiac pacemaker in situ, intracerebral vascular
clips or any other electrically sensitive support system,
clinical instability, epilepsy, severe cognitive impairment,
bilateral lesions, global aphasia, previous visual distur-
bances, depression with scores >8 in the Hospital
Anxiety and Depression Scale (HAD), pregnancy, or
other neurological diseases.
Procedures (template)
Individuals diagnosed with right-hand stroke after
discharge from the hospital will be sent to the rehabilita-
tion sector. All individuals with damage to the right
hemisphere, as confirmed by a CT or MRI scan, will be
invited to participate. The patient, a family member, or
guardian must sign a Free and Informed Consent Form.
Fig. 2 Study flow diagram for cathodal transcranial direct current stimulation (tDCS) stimulation
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After signing the Consent Form, the individuals will be
evaluated to confirm their diagnosis using BIT-C, con-
sisting of Star Cancellation (SC), Letter Cancellation
(LC), Line Crossing (LiC), Line Bisection (LB), Figure
and Shape Copying (FSC-A&B), and Representational
Drawing (RD). After confirmation of the USN diagnosis
(BIT-C >129), patients will be screened to clinical condi-
tion, the HAD, the Edinburgh Handedness Inventory to
classify laterality, and checking of the excluded criteria
for the tDCS application. After screening patients will be
randomized into the following four groups: (1) treatment
with anodal tDCS, (2) control with anodal tDCS (sham
mode), (3) treatment with cathodal tDCS, (4) control
with cathodal tDCS (sham mode). Individuals will be
assessed using the Catherine Bergego Scale (CBS), the
Mini-mental State Examination (MMSE), the National
Institutes of Health Stroke Scale (NIHSS), the Functional
Independence Measure (FIM), the Barthel Index, the
Modified Rankin Scale (mRS), and the European Quality
of Life Scale (EuroQol-5D) by an investigator who is
blinded to the treatment that the patient received before
the first session and after 1 week from the last tDCS
session (Table 1).
Randomization and blinding
The concealed randomization schedule will be estab-
lished using a computer-generated random number se-
quence, and maintained by an offsite investigator who is
neither involved with the enrollment nor with the as-
sessment of study participants. A second research assist-
ant will consecutively open consecutively numbered,
randomly ordered, opaque envelopes containing the
group allocation (in a 1:1 ratio) after the baseline assess-
ment. All the participants will receive rehabilitation
along with 45 min of physical therapy three times a week
for 5 weeks after tDCS application. The tDCS will be
applied three times a week for 5 weeks for a total of 15
sessions, wherein the patient is evaluated before the
beginning of the first session and 1 week after the last
session by a blinded investigator.
Intervention
The tDCS will be applied in accordance with the tech-
nique used by Sparing et al. [40]. The patient will be
placed in a room with minimal external influences
(noise, lamps, and electromagnetic waves), and posi-
tioned in a sitting posture with their arms and torso sup-
ported on a table at 45°. For stimulation of the right and
left posterior parietal lobes, after shaving and cleansing
the skin with alcohol, the electrodes will be placed in
positions P4 and P3 of the 10/20 International System of
Electroencephalography. The reference electrodes will be
placed on the cranial vertex (Cz). Four groups of pa-
tients will receive stimulation as follows: group 1, right
anodal stimulation (P4 anode, reference Cz), group 2,
sham control for right anodal stimulation (P4 anode,
reference Cz), group 3, left cathodal stimulation (P3
cathode, reference Cz), and group 4, sham control for
left cathodal stimulation (P3 cathode, reference Cz). For
stimulation, sponge surface electrodes (5 cm × 5 cm
square) will be soaked in saline. A continuous current of
1 mA in intensity and a resistance of less than 10 kΩ
will be applied for 1200 s with ramping up for 30 s and
ramping down for 30 s according to international safety
guidelines [38]. The tDCS will be applied using an
electrical stimulator, namely the battery-powered DC-
Stimulator Plus model, NeuroConn®.
A total of 15 sessions will be performed using a sched-
ule of three times a week for 5 weeks, wherein a blinded
examiner evaluates the patient before the beginning of
the first session and 1 week after the last session. For
the control group (sham), patients will be placed in the
Table 1 Template of recommended content for the schedule
of enrollment, interventions, and assessments
Study period
Enrollment Allocation Post allocation Close-out









Anodal tDCSd X X
Cathodal tDCSe X X
Anodal placebo X X




NIHSS, FIM and BIg X X
mRSh X X
Quality of lifei X X




dAnodal tDCS applied over left parietal lobe (P3)
eCathodal tDCS applied over right parietal lobe (P4)
fCatherine Bergego Scale
gNational Institutes of Health Stroke Scale, Functional Independence Measure
and Barthel Index
hModified Rankin Scale
iQuality of life measured by The European Quality of Life Scale (EuroQol 5D)
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same room and position, but the current that will be ap-
plied to each control group will be shut off after 30 s.
The physiotherapy protocol will be delivered after
tDCS and will be composed of saccadic eye movement
training with visual scanning exercises (VSEs) integrated
with task-specific activities. The VSEs integrated with
task-specific activities will consist of dual-task activities,
which require the ability to allocate information-
processing resources between two tasks and to maintain
sufficient attention on the visual scanning task during
the dual-task performance. The guideline of the VSEs in-
tegrated with task specific activities and the principles of
progression of these exercises follow van Wyk et al. [45],
with session durations of approximately 45 min.
Primary outcome measures
Change in the degree of USN will be measured as fol-
lows: (1) D1, as the percentage of changed in range of
BIT-C, and (2) D2, based on the CBS.
Secondary outcome measures
Disability, autonomy, and quality of life will be measured
as follows: (1) D3, as the change in neurological status
based on the NIHSS, (2) D4, as the change in functional
independence based on the Barthel Index, (3) D5, as the
change measured using the mRS, and (4) D6, as the
change in quality of life based on the EuroQol-5D. For all
of the outcomes (except for D6), the change after stimula-
tion will be calculated as follows: 100 (Vf −V0)/V0, where
V0 is the value of the prerandomization variable and Vf is
the variable value after 1 week of treatment.
Adverse effects
Any adverse effects will be reported during the study




Conventional Behavior Inattention Tasks (BIT-C): the six
conventional tasks of the BIT-C will be administered,
consisting of Star Cancellation (SC), Letter Cancellation
(LC), Line Crossing (LiC), Line Bisection (LB), Figure
and Shape Copying (FSC-A&B), and Representational
Drawing (RD). The BIT-C is usually administered to
diagnose USN and provides a range (0–146) and a cutoff
score. For all USN tests, the examiner will place the test
sheet in front of the patient with a distance of 60 cm be-
tween the paper and the glabella of the patient [47].
Catherine Bergego Scale (CBS): this test will be used to
measure the extent to which the USN interferes with
daily tasks. The scale is divided into 10 activities each
with a score of 0 to 3. The maximum scale score is 30
and the total indicates USN severity [27].
Neurological and functional evaluation
Mini-mental State Examination (MMSE): this instru-
ment is used for screening cognitive function, and pro-
vides measures of orientation, registration (immediate
memory), short-term memory (but not long-term mem-
ory) as well as language functioning. Scores of 25–30
out of 30 are considered normal; the National Institute
for Health and Care Excellence (NICE) classifies 21–24
as mild impairment, 10–20 as moderate impairment,
and <10 as severe impairment. The MMSE is used in
this trial for data characterization [48].
Edinburgh Handedness Inventory (EHI): the EHI is a
measurement scale used to assess the dominance of a
person’s right or left hand in everyday activities, some-
times referred to as laterality [49].
Hospital Anxiety and Depression Scale (HAD): the
HAD was originally developed by Zigmond and Snaith
(1983) and it is used to determine the levels of anxiety
and depression that a patient is experiencing, being
composed for fourteen items. Seven of the items relate
to anxiety and seven relate to depression. Each item on
the questionnaire is scored from 0 to 3 which means
that a person can score between 0 and 21 for either anx-
iety or depression [50].
National Institutes of Health Stroke Scale (NIHSS): this
test will be used to evaluate the effect of acute cerebral
infarction on the levels of consciousness, language,
neglect, visual-field loss, extraocular movement, motor
strength, ataxia, dysarthria, and sensory loss. The
higher the score on this scale the greater the neuro-
logical deficit [51].
Functional Independence Measure (FIM): this test will
be used to measure the functional independence and
autonomy of the subjects in six domains (self-care,
sphincter control, mobility, locomotion, communication,
and social cognition). The scale scores range from 18 to
126, and the higher the score, the better the autonomy
and independence [52].
Barthel Index: this test will be used to measure the
functional independence and autonomy of the subjects in
10 activities, namely, feeding, bathing, personal care, abil-
ity to dress, motility, urinary pace, bathroom use, transfer,
mobility, and climbing stairs. The maximum score is 100
which indicates a greater degree of autonomy [51, 53].
Modified Rankin Scale (mRS): this test will be used to
evaluate the degree of independence, and determines
whether the patient can perform self-care during activities
of daily living [51]. The scale is ordinal from 0 to 6, and
the greater the score, the worse the functional capacity.
The European (EuroQol 5D) Quality of Life Scale; this
test will be used to measure the impact of stroke on the
subject’s quality of life in five domains, namely, structured
mobility, self-care, usual activities, pain/discomfort, and
anxiety/depression. The scale scores range from 0 to 10,
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and the higher the score, the worse the perception of life
quality. At the end of the test, patients will mark their
health on an ordinal scale from 0 to 100, with a lower
score indicating poorer health [54].
Data analysis
To detect changes in continuous outcomes, a compari-
son between the anodal tDCS and the cathodal tDCS, as
well as between the tDCS and sham stimulation, will be
performed using a linear regression model with a normal
response. This analysis will be adjusted for potential
confounders, such as age, mRS score, and USN score at
baseline. This analysis approach does not test the validity
of the model’s theoretical assumptions with a normal re-
sponse. However, if a fault is identified then the com-
parison will be performed by adjusting the regression
model with an asymmetric response. In the latter case,
the comparison will be made using the nonparametric
Mann-Whitney test. Data will be analyzed using SPSS
version 22 (SPSS Inc., Chicago, IL 60606, USA), and will
be considered statistically significant at a p value < 0.05.
Discussion
In recent years, tDCS has proven to be a promising tool
in neurorehabilitation [52]. Some studies indicate that
the application of tDCS over the parietal lobe may be
beneficial for treating patients with USN after stroke
[39–41]. USN after stroke is associated with a poor func-
tional outcome and long stays in rehabilitation centers.
Although various nonpharmacological and pharmaco-
logical treatments for USN have been proposed, there is
no evidence of efficacy. Thus, studies of tDCS in the
treatment of USN may offer new insights for rehabilita-
tion in these patients [10–14].
Patients with USN after stroke have a more difficult re-
habilitation process, which is more demanding for the
stroke rehabilitation team [12]. The few studies on stroke
rehabilitation report interesting results in terms of both
USN reduction and modulation of cortical excitability.
Nonetheless, these studies report no improvements in pa-
tient functional capacity or quality of life. tDCS devices,
which are easy to use and portable, could be useful for
stroke rehabilitation because their application can modulate
the excitability of the parietal cortex after USN [55–57].
Some studies report that anodal stimulation improves USN
symptoms in patients after stroke, while others report that
cathodal stimulation enhances perceptual performance, or
that there is no difference between anodal and cathodal
stimulation [40–42]. Thus, we aim to conduct a multicenter
randomized controlled trial to investigate whether tDCS
has the potential to become a promising treatment for
USN after stroke, and to determine the best tDCS type
(anodal or cathodal) to improve the symptoms of USN.
This trial, which is one of the multicenter randomized
controlled trials to assess the efficacy of tDCS in USN after
stroke, may also shed light on whether noninvasive brain
stimulation techniques are of value in the comprehensive
treatment of USN. We are confident that our study will
answer this question and provide strong evidence of the
short- and long-term efficacy of modulating parietal lobe




BIT-C: Conventional Behavioral Inattention Tasks; CBS: Catherine Bergego
Scale; CT: Computer tomography; EHI: Edinburgh Handedness Inventory;
EuroQol: The European (5D) Quality of Life Scale; FSC-A&B: Figure and Shape
Copying; HAD: Hospital Anxiety and Depression Scale; LB: Line Bisection;
LC: Letter Cancellation; LiC: Line Crossing; MMSE: Mini-mental State
Examination; MRI: Magnetic resonance image; mRS: Modified Rankin Scale;
NIHSS: National Institutes of Health Stroke Scale; RD: Representational
Drawing; rTMS: Repetitive magnetic stimulation; SC: Star Cancellation;
tDCS: Transcranial direct current stimulation; USN: Unilateral spatial neglect
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